Key FACTS
- More than 120 employees
- Established in 1972 by Ajinomoto Omnichem, acquired in 2015 by the Minafin Group
- R&D Center for HPAPI with 20 scientists and 5 PhDs
- 17 Quality Control experts
- 80 m³ reaction capacity
- more info
The site is located in the haert of Belgium, 20 km South of Brussels, in the Flemming science park, linked to the University of Louvain-la-Neuve (UC Louvain).
Minakem High Potent (MHP) is a world leader in pharmaceutical chemistry for the development and manufacturing of highly active APIs (HAPIs), used in oncology for the treatment of cancer.